Granule exocytosis, and not the Fas/Fas ligand system, is the main pathway of cytotoxicity mediated by alloantigen-specific CD4+ as well as CD8+ cytotoxic T lymphocytes in humans

Blood

Volumn 95, Issue 7, 2000, Pages 2352-2355

  Yasukawa, Masaki ^a   Ohminami, Hideki ^b   Arai, Junko ^b   Kasahara, Yoshihito ^b   Ishida, Yasushi ^b   Fujita, Shigeru ^b  

^a EHIME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIGEN; CONCANAMYCIN A; CYTOKINE; FAS ANTIGEN; GRANZYME B; HLA ANTIGEN; PERFORIN;

ANTIGEN SPECIFICITY; ARTICLE; B LYMPHOCYTE; CELL GRANULE; CYTOKINE PRODUCTION; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; EXOCYTOSIS; FEMALE; HUMAN; HUMAN CELL; NATURAL KILLER CELL MEDIATED CYTOTOXICITY; PRIORITY JOURNAL;

EID: 0034176232     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v95.7.2352.007k40_2352_2355     Document Type: Article

References (27)

1. Henkart PA. Lymphocyte-mediated cytotoxicity: two pathways and multiple effector molecules. Immunity. 1994;1:343.
2. Kägi D, Ledermann B, Bürki K, Zinkernagel RM, Hengartner H. Molecular mechanisms of lymphocyte-mediated cytotoxicity and their role in immunological protection and pathogenesis in vivo. Annu Rev Immunol. 1996;14:207.
3. Watanabe-Fukunaga R, Brannan CI, Copeland NG, Jenkins NA, Nagata S. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature. 1992;356: 314.
4. Takahashi T, Tanaka M, Brannan CI, et al. Generated lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand. Cell. 1994;76:969.
5. Kägi D, Vignaux F, Ledermann B, et al. Fas and perform pathways as major mechanisms of T cell-mediated cytotoxicity. Science. 1994;265:528.
6. Lowin B, Hahne M, Mattmann C, Tschopp J. Cytolytic T-cell cytotoxicity is mediated through perforin and Fas lytic pathways. Nature. 1994;370: 650.
7. Walsh CM, Matloubian M, Liu C-C, et al. Immune function in mice lacking the perform gene. Proc Natl Acad Sci U S A. 1994;91:10,854.
8. Kojima H, Shinohara N, Hanaoka S, et al. Two distinct pathways of specific killing revealed by perform mutant cytotoxic T lymphocytes. Immunity. 1994;1:357.
9. Simon MM, Hausmann M, Tran T, et al. In vitro-and ex vivo-derived cytolytic leukocytes from granzyme A x B double knockout mice are defective in granule-mediated apoptosis but not lysis of target cells. J Exp Med. 1997;186:1781.
10. Kägi D, Ledermann B, Bürki K, et al. Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice. Nature. 1994;369:31.
11. + T cell-mediated cytotoxicity. J Immunol. 1994;152:1127.
12. Rieux-Laucat FR, Deist FL, Hivroz C, et al. Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity. Science. 1995;268:1347.
13. Fisher GH, Rosenberg FJ, Straus SE, et al. Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome. Cell. 1995;81:935.
14. Nagata S. Human autoimmune lymphoproliferative syndrome, a defect in the apoptosis-inducing Fas receptor: a lesson from the mouse model. J Hum Genet. 1998;43:2.
15. Kasahara Y, Wada T, Niida Y. et al. Novel Fas (CD95/APO-1) mutations in infants with a lymphoproliferative disorder. Int Immunol. 1998;10:195.
16. + CTL directed against herpes simplex virus-infected cells. J Immunol. 1999;162:6100.
17. Yasukawa M, Inatsuki A, Kobayashi Y. Helper activity in antigen-specific antibody production mediated by CD4 human cytotoxic T cell clones directed against herpes simplex virus. J Immunol. 1988;140:3419.
18. + T-cell clones. Blood. 1997;89: 1440.
19. + cytotoxic T-lymphocyte clones. J Virol. 1999;73:3623.
20. + T cells. J Immunol. 1991;146:1341.
21. Kataoka T, Shinohara N, Takamiya H, et al. Concanamycin A, a powerful tool tor characterization and estimation of contribution of perforin- and Fas-based lytic pathways in cell-mediated cytotoxicity. J Immunol. 1996;156:3678.
22. + cytotoxic T-cell clones specific for bcr-abl b3a2 fusion peptide augment colony formation by chronic myelogenous leukemia cells in a b3a2-specific and HLA-DR-restricted manner. Blood. 1998;92:3355.
23. +-independent T cell-mediated cytotoxicity. J Exp Med. 1993;177:195.
24. Lowin B, Mattman C, Hahne M, Tschopp J. Comparison of Fas (Apo-1/CD95)- and perforin-mediated cytotoxicity in primary T lymphocytes. Int Immunol. 1996;8:57.
25. Graubert TA, Russell JH, Ley TJ. The role of granzyme B in murine models of acute graft-versus-host disease and graft rejection. Blood. 1996; 87:1232.
26. + T cells mediate rejection of porcine xenografls. J Immunol. 1999;162:5256.
27. + cytotoxic T-lymphocyte clones from a patient with severe graft-versus-host disease after allogeneic bone marrow transplantation: implication for graft-versus-leukemia reaction. Blood. 1995;86:2821.